Overview

Prefilled Syringes Market is poised to register a CAGR of 10.8% during the forecast period 2022 to 2028.  

FutureWise Market Research has instantiated a report that provides an intricate analysis of Prefilled Syringes Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Prefilled Syringes Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Prefilled Syringes Market are :

• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• Vetter Pharma International Gmbh
• Weigao Group
• Catalent, Inc.
• Gerresheimer    
• Schott    
• Treumo    
• Nipro  
• Medtronic
• Stevanato (OMPI)
• Retractable Technologies
• Globe Medical Tech
• Elcam Medical
• Ypsomed
• Oval Medical Technologies Ltd.
• SHL Medical AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

Prefilled Syringes Market Segmentation:

By Material 
• Glass Prefilled Syringes
• Plastic Prefilled Syringes

By Type
• Conventional Prefilled Syringes
    o Disposable Prefilled Syringes
    o Reusable Prefilled Syringes
• Safety Prefilled Syringes

By Design 
• Single-Chamber Prefilled Syringes
• Dual-Chamber Prefilled Syringes
• Customized Prefilled Syringes

By Application
• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Cancer
• Thrombosis
• Ophthalmology
• Others

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Prefilled Syringes Market by material, by type, by design, by application by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
           1.1. Objectives of the Study 
           1.2. Market Definition 
           1.3. Market Scope 
                   1.3.1. Years Considered for the Study
                   1.3.2. Market Covered
           1.4. Currency 
           1.5. Limitations 
           1.6. Stakeholders 
 2.  Research Methodology 
           2.1. Research Data 
                   2.1.1. Secondary Data
                           2.1.1.1. Key Data from Secondary Sources
                   2.1.2. Primary Data
                            2.1.2.1. Key Data from Primary Sources
           2.2. Market Size Estimation 
           2.3. Market Breakdown and Data Triangulation 
           2.4. Assumptions for the Study  
3. Executive Summary
           3.1. Market Outlook
           3.2. Segment Outlook
           3.3. Competitive Insights
4. Prefilled Syringes Market Variables, Trends & Scope
           4.1. Market Lineage Outlook
           4.2. Penetration and Growth Prospect Mapping
           4.3. Industry Value Chain Analysis
           4.4. Cost Analysis Breakdown
           4.5. Technology Overview
           4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Prefilled Syringes Market Overview
           5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                             5.1.1.1. Increasing focus of Prefilled Syringes Companies on Brand Protection
                             5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                             5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                             5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Prefilled Syringes Market Analysis Tools
           6.1. Industry Analysis - Porter’s
                   6.1.1. Supplier Power
                   6.1.2. Buyer Power
                   6.1.3. Substitution Threat
                   6.1.4. Threat from New Entrants
                   6.1.5. Competitive Rivalry
           6.2. Pestel Analysis
                   6.2.1. Political Landscape
                   6.2.2. Environmental Landscape
                   6.2.3. Social Landscape
                   6.2.4. Technology Landscape
                   6.2.5. Legal Landscape
           6.3. Major Deals And Strategic Alliances Analysis
                   6.3.1. Joint Ventures
                   6.3.2. Mergers and Acquisitions
                   6.3.3. Licensing and Partnership
                   6.3.4. Technology Collaborations
                   6.3.5. Strategic Divestments
           6.4. Market Entry Strategies
           6.5. Case Studies
7. Prefilled Syringes Market, By Material Historical Analysis and Forecast 2022-2028 (USD Million)
           7.1. Glass Prefilled Syringes
           7.2. Plastic Prefilled Syringes
8. Prefilled Syringes Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
           8.1. Conventional Prefilled Syringes
                   8.1.1. Disposable Prefilled Syringes
                   8.1.2. Reusable Prefilled Syringes
           8.2. Safety Prefilled Syringes
9. Prefilled Syringes Market, By Design Historical Analysis and Forecast 2022-2028 (USD Million)
           9.1. Single-Chamber Prefilled Syringes
           9.2. Dual-Chamber Prefilled Syringes
           9.3. Customized Prefilled Syringes
10. Prefilled Syringes Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
           10.1. Diabetes
           10.2. Rheumatoid Arthritis
           10.3. Anaphylaxis
           10.4. Cancer
           10.5. Thrombosis
           10.6. Ophthalmology
           10.7. Others
11. North America Prefilled Syringes Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           11.1. Introduction
           11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   11.2.1. U.S.A
                   11.2.2. Canada
                   11.2.3. Mexico
           11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Prefilled Syringes Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           12.1. Introduction
           12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     12.2.1. Brazil
                     12.2.2. Venezuela
                     12.2.3. Argentina
                     12.2.4. Rest of Latin America
           12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Prefilled Syringes Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           13.1. Introduction
           13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     13.2.1. Germany
                     13.2.2. U.K         
                     13.2.3. France
                     13.2.4. Italy
                     13.2.5. Spain
                     13.2.6. Russia
                     13.2.7. Poland
                     13.2.8. Rest of Europe
           13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Prefilled Syringes Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           14.1. Introduction
           14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     14.2.1. Japan
                     14.2.2. China
                     14.2.3. India
                     14.2.4. Australia and New Zealand
                     14.2.5. ASEAN
                     14.2.6. Rest of Asia Pacific
           14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  
15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           15.1. Introduction
           15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     15.2.1. GCC
                     15.2.2. Israel
                     15.2.3. South Africa
                     15.2.4. Rest of MEA
           15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape   
           16.1. Global Landscape - Key Players, Revenue and Presence
           16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
           16.3. Global Emerging Companies
           16.4.  North America - Market Share Analysis and Key Regional Players
           16.5.  Europe - Market Share Analysis and Key Regional Players
           16.6.  Asia Pacific - Market Share Analysis and Key Regional Players
           16.7.  Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
           17.1. Becton, Dickinson and Company
                     17.1.1. Company Overview
                     17.1.2. Product Portfolio
                     17.1.3. SWOT Analysis
                     17.1.4. Financial Overview
                     17.1.5. Strategic Overview
           17.2. West Pharmaceutical Services, Inc.
                     17.2.1. Company Overview
                     17.2.2. Product Portfolio
                     17.2.3. SWOT Analysis
                     17.2.4. Financial Overview
                     17.2.5. Strategic Overview
           17.3. Vetter Pharma International Gmbh
                     17.3.1. Company Overview
                     17.3.2. Product Portfolio
                     17.3.3. SWOT Analysis
                     17.3.4. Financial Overview
                     17.3.5. Strategic Overview
           17.4. Weigao Group
                     17.4.1. Company Overview
                     17.4.2. Product Portfolio
                     17.4.3. SWOT Analysis
                     17.4.4. Financial Overview
                     17.4.5. Strategic Overview
           17.5 Catalent, Inc.
                     17.5.1. Company Overview
                     17.5.2. Product Portfolio
                     17.5.3. SWOT Analysis
                     17.5.4. Financial Overview
                     17.5.5. Strategic Overview
           17.6 Gerresheimer       
                     17.6.1. Company Overview
                     17.6.2. Product Portfolio
                     17.6.3. SWOT Analysis
                     17.6.4. Financial Overview
                     17.6.5. Strategic Overview
           17.7. Schott   
                     17.7.1. Company Overview
                     17.7.2. Product Portfolio
                     17.7.3. SWOT Analysis
                     17.7.4. Financial Overview
                     17.7.5. Strategic Overview
           17.8. Treumo   
                     17.8.1. Company Overview
                     17.8.2. Product Portfolio
                     17.8.3. SWOT Analysis
                     17.8.4. Financial Overview
                     17.8.5. Strategic Overview
           17.9. Nipro 
                     17.9.1. Company Overview
                     17.9.2. Product Portfolio
                     17.9.3. SWOT Analysis
                     17.9.4. Financial Overview
                     17.9.5. Strategic Overview
           17.10. Medtronic
                     17.10.1. Company Overview
                     17.10.2. Product Portfolio
                     17.10.3. SWOT Analysis
                     17.10.4. Financial Overview
                     17.10.5. Strategic Overview
           17.11.  Stevanato (OMPI)
                     17.11.1. Company Overview
                     17.11.2. Product Portfolio
                     17.11.3. SWOT Analysis
                     17.11.4. Financial Overview
                     17.11.5. Strategic Overview
           17.12. Retractable Technologies
                     17.12.1. Company Overview
                     17.12.2. Product Portfolio
                     17.12.3. SWOT Analysis
                     17.12.4. Financial Overview
                     17.12.5. Strategic Overview
           17.13. Globe Medical Tech
                     17.13.1. Company Overview
                     17.13.2. Product Portfolio
                     17.13.3. SWOT Analysis
                     17.13.4. Financial Overview
                     17.13.5. Strategic Overview
           17.14. Elcam Medical
                     17.14.1. Company Overview
                     17.14.2. Product Portfolio
                     17.14.3. SWOT Analysis
                     17.14.4. Financial Overview
                     17.14.5. Strategic Overview
           17.15. Ypsomed
                     17.15.1. Company Overview
                     17.15.2. Product Portfolio
                     17.15.3. SWOT Analysis
                     17.15.4. Financial Overview
                     17.15.5. Strategic Overview
           17.16. Oval Medical Technologies Ltd.
                     17.16.1. Company Overview
                     17.16.2. Product Portfolio
                     17.16.3. SWOT Analysis
                     17.16.4. Financial Overview
                     17.16.5. Strategic Overview
           17.17. SHL Medical AG
                     17.17.1. Company Overview
                     17.17.2. Product Portfolio
                     17.17.3. SWOT Analysis
                     17.17.4. Financial Overview
                     17.17.5. Strategic Overview
18. Pre and Post COVID-19 Impact
           18.1. Positive influence on the healthcare industry
           18.2. The financial disruption of the manufacturing sector
           18.3. Impact of COVID-19 on emerging companies
           18.4. Significant mandates in the healthcare regulations initiated by administrations
           18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Tables

Figures